glp-1 news 2025 november Weight-Loss Drug Demonstration Begins July 2026 GLP-1 Agonists Market Report 2025-2033,

What if I stop my GLP-1 and then choose to re-start

Gether IM, Nexoe-Larsen C, Knop FK

They increase insulin secretion in response to meals and reduce glucagon secretion, leading to more stable blood sugar control

In line with practice for similar agents, a washout period before planned pregnancy should be discussed with a healthcare professional Patients experiencing severe or persistent abdominal pain, signs of an allergic reaction, or significant changes in heart rate should seek prompt medical advice

However, these challenges are not unique to this domain and mirror those faced by other peptide systems prior to successful translation

J., Flatt, P